Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified letrozole regimen for ovulation induction in polycystic ovary syndrome
ChiCTR2300071007Phase 4Not yet recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of letrozole in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Dominant follicle rate and Ovulation rate after trigger. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on ChiCTR2300071007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071007.